These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Drug treatment of the neuroleptic malignant syndrome. Sakkas P, Davis JM, Janicak PG, Wang ZY. Psychopharmacol Bull; 1991 May; 27(3):381-4. PubMed ID: 1685592 [Abstract] [Full Text] [Related]
23. Survival of severe neuroleptic malignant syndrome in a 78-year-old man treated with dantrolene. Kimerer NB, Parker DM, Sholer CM, Trammell JR. J Okla State Med Assoc; 1990 Mar; 83(3):122-4. PubMed ID: 2319382 [Abstract] [Full Text] [Related]
36. [The neuroleptic malignant syndrome]. García Castaño J, García Roman M, Pinilla Llorente B, Gilsanz Fernández C. An Med Interna; 1989 Oct 01; 6(10):552-3. PubMed ID: 2491057 [No Abstract] [Full Text] [Related]
37. Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report. Khan A, Jaffe JH, Nelson WH, Morrison B. J Clin Psychiatry; 1985 Jun 01; 46(6):244-6. PubMed ID: 3922961 [Abstract] [Full Text] [Related]
38. Neuroleptic malignant syndrome: a dangerous complication of neuroleptic therapy. Byrd C. J Neurosci Nurs; 1993 Feb 01; 25(1):62-5. PubMed ID: 8445278 [Abstract] [Full Text] [Related]